EGFR and lung carcinoma: Also at the authors’ institution, which has an extremely low rate of patients with EGFR mutations or other targetable alterations influencing first-line treatment (Nieder et al. 2020), early radiotherapy was the prevailing strategy for patients with brain metastases from lung cancer undergoing active treatment rather than supportive, palliative measures.